How to manage constipation in patients on methadone (opioid agonist) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Constipation in Patients on Methadone Therapy

Prophylactic treatment with stimulant laxatives and stool softeners should be initiated immediately when starting methadone therapy, as constipation is the most common and persistent opioid side effect that does not improve over time. 1

Preventive Measures (First-Line Approach)

  • Prophylactic medications:

    • Stimulant laxative + stool softener combination (e.g., senna-docusate, 2 tablets every morning; maximum 8-12 tablets per day) 1
    • Increase laxative dose when increasing methadone dose 1
  • Lifestyle modifications:

    • Maintain adequate fluid intake
    • Encourage physical activity when feasible
    • Maintain adequate dietary fiber intake (note: fiber supplements like Metamucil alone are unlikely to control methadone-induced constipation) 1

When Constipation Develops (Step-Up Approach)

Step 1: Assessment

  • Assess for cause and severity of constipation
  • Rule out bowel obstruction
  • Check for other treatable causes (hypercalcemia, hypokalemia, hypothyroidism, diabetes mellitus) 1

Step 2: Initial Management

  • Titrate stool softener/laxative combination with goal of one non-forced bowel movement every 1-2 days 1
  • If impaction is present, administer glycerin suppositories or perform manual disimpaction 1

Step 3: For Persistent Constipation

  • Add bisacodyl 10-15 mg, 2-3 times daily 1
  • Consider adding another agent:
    • Magnesium hydroxide (30-60 mL daily)
    • Bisacodyl suppository daily
    • Lactulose (30-60 mL daily)
    • Sorbitol (30 mL every 2 hours × 3, then as needed)
    • Magnesium citrate
    • Polyethylene glycol (capful in 8 oz water daily) 1
  • Consider Fleet, saline, or tap water enema 1
  • If gastroparesis is suspected, add metoclopramide (10-20 mg PO three times daily) 1

Step 4: Refractory Constipation

  • Consider methylnaltrexone 0.15 mg/kg subcutaneously every other day (maximum once daily) for constipation that hasn't responded to standard laxative therapy 1
    • Contraindicated in patients with bowel obstruction or postoperative ileus 1
    • Shown to effectively reverse methadone-induced constipation without affecting analgesia or causing withdrawal symptoms 2, 3

Important Clinical Considerations

  • Unlike other opioid side effects, constipation generally does not improve over time and requires ongoing management 1
  • Patients on methadone maintenance therapy are particularly susceptible to constipation and may require aggressive prophylactic treatment 2
  • Regular assessment of bowel function is essential - aim for bowel movements every 1-2 days 1
  • Consider opioid rotation if constipation remains intractable despite multiple interventions 1
  • Avoid bulk-forming laxatives alone (e.g., Metamucil) as they are typically insufficient for opioid-induced constipation 1

Common Pitfalls to Avoid

  1. Waiting for constipation to develop rather than initiating prophylactic treatment
  2. Failing to increase laxative doses when methadone doses are increased
  3. Relying solely on increased fluid intake and dietary modifications
  4. Not recognizing that constipation is the most common reason patients abandon opioid therapy 4
  5. Overlooking the need for regular reassessment of bowel function
  6. Delaying use of peripherally-acting μ-opioid receptor antagonists like methylnaltrexone in refractory cases

By following this algorithmic approach to managing methadone-induced constipation, clinicians can significantly reduce patient discomfort and improve treatment adherence.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Methylnaltrexone: the answer to opioid-induced constipation?

Expert opinion on pharmacotherapy, 2009

Research

Management of opioid-induced constipation.

Current pain and headache reports, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.